Loading…
← CockpitCompetitor Analysis › 2225.HK Jinhai Medical Technology LimitedOpen in the cockpit ↗

Jinhai Medical Technology Limited2225.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Industrials›Personnel Services

Diversified holding company: manpower outsourcing and dormitory services in Singapore plus minimally-invasive-surgery products in China.

≈ A conglomerate mixing a Singapore staffing agency with a small Chinese medical-device unitMomentum strong 64
Mkt cap
$3.02B
US dollars, full cap
Free float
46%
of shares outstanding
$/day
$1.52M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-26.1 pp
WACC 5.5%
Hurdle
n/a
no reverse DCF
Close · HKDHK$4.45
1D+1.0%
1W+23.6%
1M-3.0%
3M-5.3%
6M-6.1%
YTD+256.0%
1Y+323.8%
ATR %8.6%
52w lowhigh36.3% off high

What Jinhai Medical Technology does

Diversified holding company: manpower outsourcing and dormitory services in Singapore plus minimally-invasive-surgery products in China.

Supplies foreign workers to construction and marine firms in Singapore, which pay monthly fees, and rents beds in dormitories, so headcount placed and occupancy set results; Singapore's quotas and levies on foreign workers constrain the business. The medical-products unit in China is a separate venture.

In one line: A conglomerate mixing a Singapore staffing agency with a small Chinese medical-device unit.

Products and services

  • Manpower outsourcing (Singapore)
  • Worker dormitory services
  • Construction ancillary services
  • Minimally invasive surgery products
  • IT services

Customers

  • Singapore construction/marine employers
  • Chinese hospitals (medical unit)

Where it sits in the supply chain

  • Diversified holding company
  • Personnel/manpower services
  • Medical devices (minor segment)

What could go right

  • Singapore foreign-worker demand

What could go wrong

  • Singapore labor-policy changes
  • Segment complexity/holding-co discount

Moat: none. Low-margin staffing/dormitory business with little differentiation.

Headquarters: Wan Chai, Hong Kong · Founded: 2006 · Employees: 485

Named competitors

Jinhai Medical Technology at a glance

Size Jinhai Medical Technology (2225.HK) is a Hong Kong Industrials company (Personnel Services) with a market value of $3.02B, the 337th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$4.45 on 6 Nov 2026.

Performance Over six months the shares fell 6.1%, against +24.6% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — lowest of 16 in its peer set.

Growth Revenue grew 75.4% over the last twelve months (peer median +0.1%); the operating margin is -16.6% (peer median 4.5%).

Valuation It trades at 58.9× enterprise value to sales against a peer median of 0.8× (most expensive of 16).

Capital Return on invested capital runs 26.1 points below its cost of capital (5.5% WACC).

Relative performance

10015011 May 202611 Aug 20266 Nov 2026Peer median 1362225.HK 101
Six months, rebased to 100: Jinhai Medical Technology against the median of its 15 peers (local-currency closes).

Jinhai Medical Technology financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$400MHK$276MHK$293MHK$266MHK$127M
Revenue growth—-6%+10%+110%—
Gross profitHK$71.4MHK$42.9MHK$67.0MHK$70.1MHK$57.4M
EBITDA-HK$28.8M-HK$79.9M-HK$88.0M-HK$2.87MHK$24.9M
Net income-HK$68.0M-HK$102M-HK$105M-HK$18.3MHK$2.66M
Free cash flow-HK$52.2M-HK$37.4M-HK$27.6M-HK$17.5MHK$19.4M
Capital expenditureHK$17.9MHK$566,835HK$5.79MHK$7.20MHK$6.69M
Total debtn/aHK$90.2MHK$82.7MHK$59.7MHK$25.9M

Quarterly statements and history in the cockpit →

Jinhai Medical Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+20%+40%+60%+80%-20%0%+20%2181KFYRHIMANADEN2175UPWKHAS2124RAND2154KFRCGPPPAGE21462225.HK6-month return →1-month return →
Up and to the right = strong over both horizons. Jinhai Medical Technology is the large dot.

Fundamentals: revenue growth against valuation

0%+25%+50%+75%0×20×40×60×2181KFYRHI2175HAS21462225.HKRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Jinhai Medical Technology is the large dot.

Jinhai Medical Technology competitors and peer comparison

Head to head with its named competitors (2225.HK vs MAN vs 6098.T)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
Jinhai Medical Technology 2225.HK$3.02B-6%+75%-17%58.9×n/a
ManpowerGroup MAN$2.07B+49%+7%2%0.2×-0.4%
Recruit 6098.T$149B+133%+9%20%5.9×22.0%

How Jinhai Medical Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Jinhai Medical Technology against its 15 peers (data as of 6 Nov 2026)
Measure2225.HKPeer medianRank in peer set
1-month return-3.0%+2.3%6th lowest of 16
6-month return-6.1%+24.6%lowest of 16
Distance from 52-week high-36.3%-12.3%2nd lowest of 16
Revenue growth (TTM)+75.4%+0.1%highest of 16
Operating margin-16.6%4.5%lowest of 16
EV / Sales58.9×0.8×most expensive of 16
ROIC minus cost of capital-26.1 pp+8.4 pplowest of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Jinhai Medical Technology 2225.HKHong Kong$3.02B-6%+75%-17%58.9×n/an/a
Persol 2181.TJapan$4.11B+22%+10%4%0.4×-10.3%+10.4%
Korn Ferry KFYUnited States$4.11B+11%+7%13%1.3×2.0%+10.1%
Robert Half RHIUnited States$4.28B+55%-3%1%0.8×26.7%+1.0%
ManpowerGroup MANUnited States$2.07B+49%+7%2%0.2×-0.4%0.0%
Adecco ADEN.SWSwitzerland$4.82B+24%0%2%0.3×-3.5%+0.7%
SMS 2175.TJapan$1.31B+33%+8%11%2.9×19.2%+12.5%
Upwork UPWKUnited States$1.26B+14%-1%18%1.3×-7.1%+16.1%
Hays HAS.LUnited Kingdom$1.24B+75%-3%1%0.2×18.3%+2.6%
JAC Recruitment 2124.TJapan$1.21B+34%+12%26%3.5×-1.0%+16.4%
Randstad RAND.ASNetherlands$8.14B+69%0%3%0.4×1.1%+2.2%
Open Up 2154.TJapan$1.11B+12%-11%10%1.0×-6.5%+11.1%
Kforce KFRCUnited States$970M+25%+2%5%0.8×9.8%-1.0%
Grupa Pracuj spolka akcyjna GPP.WAPoland$919M+23%+5%37%4.1×-1.9%+22.1%
Michael Page PAGE.LUnited Kingdom$896M+60%-3%2%0.5×23.5%+4.1%
UT Group Co.,Ltd. 2146.TJapan$868M+22%-13%7%0.7×6.7%+7.7%

Questions

Who are Jinhai Medical Technology's main competitors?
Named competitors: ManpowerGroup (MAN), Recruit Holdings (6098.T). The cockpit's measured peer set (industry) also includes Persol (2181.T), Korn Ferry (KFY), Robert Half (RHI), ManpowerGroup (MAN), Adecco (ADEN.SW), SMS (2175.T).
Is Jinhai Medical Technology expensive compared with its peers?
On ev / sales it trades at 58.9× against a peer median of 0.8×, most expensive of 16 in its peer set.
How has Jinhai Medical Technology stock performed?
Over six months to 6 Nov 2026 the shares returned -6.1% against +24.6% for the median peer; over one year +323.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.